CLOVIS ONCOLOGY Forum: Community User: Maroni

Clovis Oncology (CLVS +10.9%) perks up on increased volume in response to its announcement that the FDA has informed it that it has no plans to hold an Advisory Committee meeting to discuss the company's New Drug Application (NDA) seeking accelerated approval of rucaparib for the treatment of ovarian cancer, normally a bullish development. The FDA's action date (PDUFA) is February 23, 2017. The market has been discounting the positive news for some time now. Shares are up 132% since bottoming at $11.57 on June 27. Previously: FDA to review Clovis' rucaparib NDA for ovarian cancer, action date in six months; shares jump 31% (Aug. 23)

Geil;)

ich glaube hier geht's noch was!!!

googel

Was isn onkologie?

Biotech im Bereich Onkologie

http://clovisoncology.com/products-companion-diagnostics/

Was macht des unternehmen eigentlich?

Gratuliere, wer gehalten hat wird jetzt belohnt. Kannte die aktie gar nicht.

http://www.cnbc.com/2016/08/23/clovis-shares-rocket-higher-after-fda-decision.html

Anhebung auf 30 usd Kursziel

was gibts hier für news??? danke euch

Gratulation! schöner anstieg

War grad kurzfristig auf 22 usd xD Zitat aus us Forum: “Halted! This is HUGE news! Where does CLVS open?“

Handel ausgesetzt!!

PDUFA date set for Feb 23